Open access
8,019
Views
6
CrossRef citations to date
0
Altmetric
Review
Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies
Robert J. Motzera Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, NY, USACorrespondence[email protected]
View further author information
, View further author information
Matthew H. Taylorb Division of Hematology and Oncology, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USAView further author information
, Thomas R. Jeffry Evansc Institute of Cancer Sciences, University of Glasgow, Glasgow, UK;d Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UKView further author information
, Takuji Okusakae Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, JapanView further author information
, Hilary Glend Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UKView further author information
, Gregory M. Lubinieckif Global Clinical Development, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USAView further author information
, Corina Dutcusg Clinical Research, Eisai Inc., Nutley, NJ, USAView further author information
, Alan D. Smithg Clinical Research, Eisai Inc., Nutley, NJ, USAView further author information
, Chinyere E. Okparag Clinical Research, Eisai Inc., Nutley, NJ, USAView further author information
, Ziad Husseinh Clinical Pharmacology Science, Eisai Europe Ltd, Hatfield, UKView further author information
, Seiichi Hayatoi Clinical Pharmacology Science, Eisai Co., Ltd, Tokyo, JapanView further author information
, Toshiyuki Tamaij Clinical Research, Eisai Co., Ltd, Tokyo, JapanView further author information
& Vicky Makkera Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, NY, USAView further author information
show all
Pages 383-400
|
Received 23 Dec 2021, Accepted 03 Feb 2022, Published online: 07 Apr 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.